Truveta will enable The CHOICE Institute with complete, timely, and clean real-world data to improve patient care and advance medicine The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has...
In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data – now published in JAMA Internal Medicine – Truveta Research found that patients with overweight or obesity taking tirzepatide were...
With industry-leading certifications and rigorous third-party audits, Truveta announces new capabilities to enable successful regulatory submissions and audits. BELLEVUE, Wash. – June 18, 2024 – Today, Truveta announced regulatory and audit capabilities to support its...
BELLEVUE, Wash. – May 13, 2024 – Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors...
From detailed family history and complex concepts from a wide range of therapeutic areas to millions of de-identified medical images, Truveta empowers researchers with the most complete, timely, and clean data. BELLEVUE, Wash. – May 2, 2024 – Today Truveta announced...
